arrow
drop
search
cross
Select login type
x
My Account Login
Working Group's Member Login
CHOOSE A PAGE TO ACCESS
x
WGXI Patient Involvement: Workplans, drafts, TC notes ...
WGXI Patient Involvement: Background Documents
WGXI Patient Involvement: Face-to-face meetings
WGXII Benefit-risk Working Group Documents
WGXII Benefit-risk Working Group Documents
WGXIII Real-world Data Working Group Documents
SCAR Working Group Documents
Educational Standards Working Group Documents
Good Governance Practice for Research Institutions Working Group Documents
Pharmacoepidemiology for Public Health Working Group Documents
MedDRA Labelling Groupings Working Group Documents
Clinical Research in Resource-limited Settings Working Group Documents
Login
MENU
Login
Areas of work
Bioethics
Pharmacovigilance
Product Development
Publications
Recent
Translations
Earlier
All
Working groups
Working Group XV – Pharmacoepidemiology for Public Health
Working Group XIV Artificial Intelligence in Pharmacovigilance
Educational Standards
Severe Cutaneous Adverse Reactions – SCAR
Working Group XII – Benefit-Risk Balance for Medicinal Products
Future Working Groups
Former Working Groups
Events & Training
Online training
Webinars
Meetings & Conferences
Students
Annual Award
About cioms
Contact
About
Our History
Governance
Executive committee
Collaborations
News
Newsletters
CIOMS in the media
Membership
CIOMS Members
Invoice Payment
search
CIOMS in the media
Home
CIOMS in the media
Page 8
TIMELINE:
2024
2023
2022
2021
2020
2019
2018
2017
22/12
2023
Therapeutic Innovation & Regulatory Science
Predicting the Addition of Information Regarding Clinically Significant Adverse Drug Reactions to Japanese Drug Package Inserts Using a Machine-Learning Model
more
28/12
2023
The Ethical Obligation for Research During Public Health Emergencies: Insights From the COVID-19 Pandemic
more
28/12
2023
Pharmacological Research
Roadmap to DILI research in Europe. A proposal from COST Action ProEuroDILINet
more
8 of 8
« Previous
1
…
6
7
8
Hit enter to search or ESC to close
